Clinical Trials Browser

Phase 4 × Breast Neoplasms × 90 days × Clear all

NCT07630948 2026-06-05

riboADHERE

Phase 4 Not yet recruiting

Breast Neoplasms, Medication Adherence

NCT06274515 2026-06-04

REMERGE

Phase 4 Recruiting

Breast Neoplasms

NCT04921137 2026-05-28

Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer

Phase 4 Recruiting

Breast Neoplasms

NCT07252726 2026-05-27

Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers

Phase 4 Recruiting

BreastGenitourinary

Breast Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

NCT04764292 2026-05-22

SCEMAM

Phase 4 Completed

615 enrolled 11 charts

Breast Neoplasms

NCT07599137 2026-05-20

ADES

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07600164 2026-05-20

Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07583134 2026-05-15

B-BIT

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07589699 2026-05-15

Trastuzumab Rezetecan (T-DXh) in HER2+ Breast Cancer With Non-pCR After TCbHP

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07578064 2026-05-11

A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients

Phase 4 Recruiting

Breast Neoplasms

NCT07195344 2026-05-05

TDXdose

Phase 4 Recruiting

Breast Neoplasms

NCT02004834 2026-05-04

Levobupivacaine and Lidocaine for Paravertebral Block Causes Greater Hemodynamic Oscillations Than Levobupivacaine

Phase 4 Active not recruiting

Bradycardia, Breast Neoplasms, Hypotension

NCT05562518 2026-04-30

GRACE

Phase 4 Active not recruiting

Breast Neoplasms

NCT01574170 2026-04-17

METAL3

Phase 4 Completed

Breast Neoplasms

NCT01127295 2026-04-14

PHACS

Phase 4 Completed

Breast Neoplasms

NCT01553903 2026-04-14

OXYTAM

Phase 4 Completed

Breast Neoplasms

NCT01612871 2026-04-14

MIRHO

Phase 4 Completed

Breast Neoplasms

NCT07220967 2026-04-09

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

Phase 4 Recruiting

Breast Neoplasms

NCT04549207 2026-04-07

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

Phase 4 Active not recruiting

Breast Neoplasms

NCT05365230 2026-04-07

A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer

Phase 4 Completed

Breast Neoplasms

NCT05161195 2026-04-02

Roll-over Study to Allow Continued Access to Ribociclib

Phase 4 Active not recruiting

Breast Neoplasms

NCT05754528 2026-04-02

REaCT-TEMPO

Phase 4 Active not recruiting

Breast Neoplasms

NCT07490509 2026-04-01

DOSABEMA

Phase 4 Not yet recruiting

Breast Neoplasms

NCT07487129 2026-03-23

Clinical and P

Phase 4 Completed

Breast Neoplasms

NCT00904410 2026-03-13

CHIMTEP

Phase 4 Completed

Adenocarcinoma, Breast Neoplasms

NCT07257484 2026-03-13

Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors

Phase 4 Not yet recruiting

Breast Neoplasms, Obesity